Kristian Humer - Nov 14, 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Financial Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer
Stock symbol
FHTX
Transactions as of
Nov 14, 2025
Transactions value $
$0
Form type
4
Date filed
11/17/2025, 04:01 PM
Previous filing
May 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Humer Kristian Chief Financial Officer 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE /s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer 2025-11-17 0001872280

Kristian Humer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The Reporting Person resigned as Chief Financial Officer of Foghorn Therapeutics Inc., effective November 14, 2025. This Form 4 is being filed solely as a voluntary exit Form 4 indicating that no further reporting will be required of the Reporting Person.